Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.

about

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?

P2860

Q42287385-FAB6DAD4-3614-4E35-A750-DCB0E0EE14A9 Q42362028-A03ED3EC-EDE6-4F49-ACC3-88EF29735E21

P2860

Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.

Item

http://www.wikidata.org/entity/Q41378943

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Phase II study of interim PET- ...... n advanced Hodgkin's lymphoma.

@en

type

Item

label

Phase II study of interim PET- ...... n advanced Hodgkin's lymphoma.

@en

prefLabel

Phase II study of interim PET- ...... n advanced Hodgkin's lymphoma.

@en

P1476

Phase II study of interim PET- ...... in advanced Hodgkin's lymphoma

@en

P2093

K Kannan

http://www.w3.org/2001/XMLSchema#string

K M Lakshmipathy

http://www.w3.org/2001/XMLSchema#string

K Udupa

http://www.w3.org/2001/XMLSchema#string

P Ganesan

http://www.w3.org/2001/XMLSchema#string

R Krishnakumar

http://www.w3.org/2001/XMLSchema#string

R Rajendranath

http://www.w3.org/2001/XMLSchema#string

S Rajaraman

http://www.w3.org/2001/XMLSchema#string

S Sundersingh

http://www.w3.org/2001/XMLSchema#string

T G Sagar

http://www.w3.org/2001/XMLSchema#string

T S Ganesan

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Treatment of Hodgkin lymphoma: a 50-year perspective.

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

P304

1170-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDV077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Venkatraman Radhakrishnan

P577

2015-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25701453

http://www.w3.org/2001/XMLSchema#string

Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.

about

P2860

P2860

Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698